Artemether

April 3, 2026

💊 Artemether (蒿甲醚) | Fast-Acting Antimalarial API for Pharmaceutical Applications

🧪 Product Overview

Artemether (CAS 71963-77-4) is a highly effective antimalarial active pharmaceutical ingredient (API) derived from artemisinin. It is widely used in artemisinin-based combination therapies (ACTs) for the rapid treatment of Plasmodium falciparum malaria.

With its rapid onset of action, strong parasite clearance ability, and good safety profile, Artemether plays a critical role in global malaria control programs and modern pharmaceutical formulations.

🔬 Key Features & Performance

⚡ Rapid antimalarial activity with fast symptom relief
🧬 High efficacy against Plasmodium falciparum
💊 Widely used in ACT formulations (combined with lumefantrine, etc.)
🛡️ Good safety and tolerability profile
🔬 Suitable for oral and injectable formulations
📈 Stable quality for large-scale pharmaceutical production

⚗️ Chemical & Research Applications

Artemether is widely used in:

Development of antimalarial drug formulations
Pharmacological and mechanism-of-action studies
API research and formulation optimization
Preclinical and clinical pharmaceutical research

🏭 Industrial & Pharmaceutical Applications

In industrial applications, Artemether is used for:

Manufacturing of finished antimalarial drugs
Artemisinin-based combination therapy (ACT) production
Global health and public medical supply programs
Large-scale API production for regulated markets

📊 Specifications

Item	Specification
Appearance	White or almost white crystalline powder
Molecular Formula	C16H26O5
Molecular Weight	298.37
CAS No.	71963-77-4
Purity	≥ 98%
Grade	Pharmaceutical Grade